Peptidoglycan-linked protein A promotes T celldependent antibody expansion during Staphylococcus aureus infection

Proceedings of the National Academy of Sciences of the United States of America

Volumn 113, Issue 20, 2016, Pages 5718-5723

  Keun Kim, Hwan ^a   Falugi, Fabiana ^a   Missiakas, Dominique M ^a   Schneewind, Olaf ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

B cell superantigen; RIPK2; Staphylococcal protein A; T cell; VH3 clonal antibody

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; CRYOPYRIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; PATHOGEN ASSOCIATED MOLECULAR PATTERN; PEPTIDOGLYCAN; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE 2; STAPHYLOCOCCUS PROTEIN A; BACTERIUM ANTIBODY;

ADAPTIVE IMMUNITY; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN BINDING; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; BACTERIAL CELL WALL; BACTERIAL GROWTH; BACTERIAL MEMBRANE; CD4+ T LYMPHOCYTE; CELL CLONING; CELL EXPANSION; CONTROLLED STUDY; INNATE IMMUNITY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN DOMAIN; TANDEM REPEAT; UPREGULATION; ANIMAL; ANTIBODY PRODUCTION; BAGG ALBINO MOUSE; BIOSYNTHESIS; BLOOD; C57BL MOUSE; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY FORMATION; MICE, INBRED BALB C; MICE, INBRED C57BL; PEPTIDOGLYCAN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL PROTEIN A; STAPHYLOCOCCUS AUREUS; T-LYMPHOCYTES;

EID: 84969776847     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1524267113     Document Type: Article

References (48)

1. Fitzgerald JR (2012) Livestock-associated Staphylococcus aureus: Origin, evolution and public health threat. Trends Microbiol 20(4):192-198.
2. van Belkum A, et al. (2009) Co-evolutionary aspects of human colonisation and infection by Staphylococcus aureus. Infect Genet Evol 9(1):32-47.
3. Wertheim HF, et al. (2004) Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 364(9435):703-705.
4. Kluytmans J, van Belkum A, Verbrugh H (1997) Nasal carriage of Staphylococcus aureus: Epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 10(3):505-520.
5. Cheng AG, DeDent AC, Schneewind O, Missiakas D (2011) A play in four acts: Staphylococcus aureus abscess formation. Trends Microbiol 19(5):225-232.
6. Fowler VG, Jr, et al. (1999) Recurrent Staphylococcus aureus bacteremia: Pulsed-field gel electrophoresis findings in 29 patients. J Infect Dis 179(5):1157-1161.
7. Chang FY, et al. (2003) Staphylococcus aureus bacteremia: Recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore) 82(5): 333-339.
8. Chambers HF, Deleo FR (2009) Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol 7(9):629-641.
9. Klevens RM, et al.; Active Bacterial Core surveillance (ABCs) MRSA Investigators (2007) Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298(15):1763-1771.
10. Klevens RM, Edwards JR, Gaynes RP; National Nosocomial Infections Surveillance System (2008) The impact of antimicrobial-resistant, health care-associated infections on mortality in the United States. Clin Infect Dis 47(7):927-930.
11. Pauli NT, et al. (2014) Staphylococcus aureus infection induces protein A-mediated immune evasion in humans. J Exp Med 211(12):2331-2339.
12. 2 fragment of human IgG. Scand J Immunol 12(1):23-31.
13. Sasso EH, Silverman GJ, Mannik M (1989) Human IgM molecules that bind staphylococcal protein A contain VHIII H chains. J Immunol 142(8):2778-2783.
14. Forsgren A, Svedjelund A, Wigzell H (1976) Lymphocyte stimulation by protein A of Staphylococcus aureus. Eur J Immunol 6(3):207-213.
15. Goodyear CS, Silverman GJ (2003) Death by a B cell superantigen: In vivo VH-targeted apoptotic supraclonal B cell deletion by a staphylococcal toxin. J Exp Med 197(9): 1125-1139.
16. Goodyear CS, Silverman GJ (2004) Staphylococcal toxin induced preferential and prolonged in vivo deletion of innate-like B lymphocytes. Proc Natl Acad Sci USA 101(31):11392-11397.
17. Silverman GJ, Goodyear CS (2006) Confounding B-cell defences: Lessons from a staphylococcal superantigen. Nat Rev Immunol 6(6):465-475.
18. Silverman GJ, et al. (2000) A B cell superantigen-induced persistent "hole" in the B-1 repertoire. J Exp Med 192(1):87-98.
19. Viau M, Zouali M (2005) Effect of the B cell superantigen protein A from S. aureus on the early lupus disease of (NZBxNZW) F1 mice. Mol Immunol 42(7):849-855.
20. Schneewind O, Fowler A, Faull KF (1995) Structure of the cell wall anchor of surface proteins in Staphylococcus aureus. Science 268(5207):103-106.
21. Mazmanian SK, Liu G, Ton-That H, Schneewind O (1999) Staphylococcus aureus sortase, an enzyme that anchors surface proteins to the cell wall. Science 285(5428): 760-763.
22. Becker S, Frankel MB, Schneewind O, Missiakas D (2014) Release of protein A from the cell wall of Staphylococcus aureus. Proc Natl Acad Sci USA 111(4):1574-1579.
23. Cheng AG, et al. (2009) Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues. FASEB J 23(10):3393-3404.
24. Falugi F, Kim HK, Missiakas DM, Schneewind O (2013) Role of protein A in the evasion of host adaptive immune responses by Staphylococcus aureus. MBio 4(5):e00575-13.
25. Kim HK, Cheng AG, Kim H-Y, Missiakas DM, Schneewind O (2010) Nontoxigenic protein A vaccine for methicillin-resistant Staphylococcus aureus infections in mice. J Exp Med 207(9):1863-1870.
26. Abrahmsén L, Moks T, Nilsson B, Hellman U, Uhlén M (1985) Analysis of signals for secretion in the staphylococcal protein A gene. EMBO J 4(13B):3901-3906.
27. Guss B, et al. (1984) Region X, the cell-wall-attachment part of staphylococcal protein A. Eur J Biochem 138(2):413-420.
28. Sjödahl J (1977) Repetitive sequences in protein A from Staphylococcus aureus. Arrangement of five regions within the protein, four being highly homologous and Fc-binding. Eur J Biochem 73(2):343-351.
29. Schneewind O, Model P, Fischetti VA (1992) Sorting of protein A to the staphylococcal cell wall. Cell 70(2):267-281.
30. Forsgren A (1970) Significance of protein A production by staphylococci. Infect Immun 2(5):672-673.
31. McCarthy AJ, Lindsay JA (2010) Genetic variation in Staphylococcus aureus surface and immune evasion genes is lineage associated: Implications for vaccine design and host-pathogen interactions. BMC Microbiol 10:173.
32. Uhlén M, et al. (1984) Complete sequence of the staphylococcal gene encoding protein A. A gene evolved through multiple duplications. J Biol Chem 259(3): 1695-1702.
33. Shopsin B, et al. (1999) Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J Clin Microbiol 37(11):3556-3563.
34. Votintseva AA, et al. (2014) Prevalence of Staphylococcus aureus protein A (spa) mutants in the community and hospitals in Oxfordshire. BMC Microbiol 14:63.
35. Hollingshead SK, Fischetti VA, Scott JR (1987) Size variation in group A streptococcal M protein is generated by homologous recombination between intragenic repeats. Mol Gen Genet 207(2-3):196-203.
36. de Château M, Björck L (1996) Identification of interdomain sequences promoting the intronless evolution of a bacterial protein family. Proc Natl Acad Sci USA 93(16): 8490-8495.
37. Ziegler K, Unanue ER (1979) The specific binding of Listeria monocytogenes-immune T lymphocytes to macrophages. I. Quantitation and role of H-2 gene products. J Exp Med 150(5):1143-1160.
38. McDevitt HO, Chinitz A (1969) Genetic control of the antibody response: Relationship between immune response and histocompatibility (H-2) type. Science 163(3872): 1207-1208.
39. Romagnani S, et al. (1985) Role of class II histocompatibility antigens in Staphylococcus aureus protein A-induced activation of human T lymphocytes. Cell Immunol 90(1):52-64.
40. Caruso R, Warner N, Inohara N, Núñez G (2014) NOD1 and NOD2: Signaling, host defense, and inflammatory disease. Immunity 41(6):898-908.
41. Park JH, et al. (2007) RICK/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs. J Immunol 178(4):2380-2386.
42. Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ (1999) Peptidoglycanand lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2. J Biol Chem 274(25):17406-17409.
43. Schroder K, Tschopp J (2010) The inflammasomes. Cell 140(6):821-832.
44. Nimmerjahn F, Ravetch JV (2010) Antibody-mediated modulation of immune responses. Immunol Rev 236(1):265-275.
45. Abdelnour A, Tarkowski A (1993) Polyclonal B-cell activation by an arthritogenic Staphylococcus aureus strain: Contribution of T-cells and monokines. Cell Immunol 147(2):279-293.
46. Ziegler C, et al. (2011) The dynamics of T cells during persistent Staphylococcus aureus infection: From antigen-reactivity to in vivo anergy. EMBO Mol Med 3(11):652-666.
47. Palmqvist N, Silverman GJ, Josefsson E, Tarkowski A (2005) Bacterial cell wallexpressed protein A triggers supraclonal B-cell responses upon in vivo infection with Staphylococcus aureus. Microbes Infect 7(15):1501-1511.
48. McAdow M, et al. (2012) Coagulases as determinants of protective immune responses against Staphylococcus aureus. Infect Immun 80(10):3389-3398.